Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myeloma.
Targeting vasculogenesis to prevent progression in multiple myeloma.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myeloma.
Delineating the mTOR kinase pathway using a dual TORC1/2 inhibitor, AZD8055, in multiple myeloma. Mol Cancer Ther. 2014 Nov; 13(11):2489-500.
View in:
PubMed
subject areas
Animals
Apoptosis
Cell Line, Tumor
Cell Proliferation
Humans
Mice
Morpholines
Multiple Myeloma
Signal Transduction
TOR Serine-Threonine Kinases
Xenograft Model Antitumor Assays
authors with profiles
Yuko Mishima